Can Blocking Nitric Oxide Improve Sperm Quality? What the Science Says
"A new study reveals the complex role of nitric oxide in sperm capacitation, potentially unlocking new treatments for male infertility."
For many couples, the journey to parenthood isn't always straightforward. Male infertility is a significant factor, and understanding sperm function is key to overcoming these challenges. After sperm leave the testicles, they mature and gain the ability to move, but they still can't fertilize an egg until they undergo a process called capacitation. This complex process enables sperm to penetrate and fertilize an egg. While scientists have been studying capacitation for about half a century, the precise molecular details, especially in bovine sperm, remain somewhat mysterious.
One molecule of particular interest is nitric oxide (NO). NO is a free radical with a short life span, playing many roles in the body. It's produced from L-arginine by enzymes called nitric oxide synthases (NOS). There are several types of NOS, including neuronal NOS (nNOS), endothelial NOS (eNOS), mitochondrial NOS (mtNOS), and inducible NOS (iNOS). Researchers are particularly interested in how NO and these different NOS enzymes affect sperm.
Previous research has shown that NO can stimulate sperm motility in various animals, including mice, hamsters, and humans. It also plays a role in the acrosome reaction (essential for fertilization) in mice and bulls and helps sperm bind to the zona pellucida (the outer layer of the egg) in humans. A study on bovine sperm demonstrated that NO promotes capacitation in cryopreserved sperm, but its effects are less potent than heparin. Furthermore, sperm produce NO during heparin-induced capacitation, suggesting NO's involvement in membrane integrity, vigor, and motility during this process. Given these intriguing clues, a recent study aimed to investigate the precise role of iNOS in sperm capacitation, seeking to uncover the underlying biochemical mechanisms.
Nitric Oxide in Sperm Biology
A Crossref record identifies research on the nitric oxide synthase of mouse spermatozoa. The same record cites work on the role of nitric oxide in the quality of fresh bovine spermatozoa during heparin-induced capacitation in vitro. Together, these references show that nitric oxide has been investigated in sperm enzyme biology and sperm-quality processes across mouse and bovine models.
Semen Analysis and Its Limits
Semen analysis is described as the first step in identifying male-factor infertility, with standardized methods that support assessment of sperm quality and comparison among laboratories. Population-based reference ranges are available for standard semen and sperm parameters, and the World Health Organization's latest cited criteria are the fifth edition, published in 2010. However, recent reviews emphasize that semen evaluation has limitations, requiring strict quality control, certified andrology laboratories, comprehensive assessment, and additional sperm-specific assays.
From Observation to Omics
A 2025 scoping review identifies the discovery of spermatozoa, the development of semen analysis, and recognition of the hypothalamic-pituitary-gonadal axis as major milestones in male fertility assessment and treatment. It also lists assisted reproductive technologies and contemporary omics-based diagnostics among later developments. A separate historical chapter describes the evolution of andrology and male reproductive treatments, noting that male infertility has historically been overlooked despite its importance.
How Does Blocking iNOS Affect Sperm Capacitation?
To investigate the role of iNOS, the researchers used aminoguanidine (AG), a selective iNOS inhibitor. While AG is a potent iNOS inhibitor at lower concentrations, it's a weaker inhibitor of nNOS and eNOS at higher concentrations. The study evaluated how AG affected bovine sperm motility, vigor, and plasma membrane integrity at different time points (15, 60, 120, 180, 240, and 300 minutes). They also assessed mitochondrial activity and capacitation after 300 minutes of culture. Different concentrations of AG (0.001, 0.01, and 0.1 M) were added during heparin-induced capacitation. In some cases, sodium nitroprusside (SNP), an NO donor, was added to see if it could reverse the effects of AG.
- High AG concentrations impair sperm: Adding 0.1 M of AG decreased sperm motility, vigor, and membrane integrity (P<0.05).
- SNP partially reverses damage: Adding SNP to the culture with 0.1 M AG only restored membrane integrity after 300 minutes.
- Mitochondrial activity unaffected: Blocking NO synthesis with AG didn't change mitochondrial activity.
- Reduced oocyte penetration: Sperm treated with 0.01 and 0.1 M AG had reduced success in penetrating oocytes (20.3% and 100% decrease, respectively, P<0.05). However, when the outer layers of the oocytes were removed, penetration increased by 15% with sperm treated with 0.1 M AG.
Nitric Oxide and Capacitation
In bovine sperm, L-arginine treatment produced the highest percentage of capacitated sperm among the tested groups. The reported values were 69.8 ± 3.4% for L-arginine, compared with 51.2 ± 3.0% for the control, 51.1 ± 2.1% for Rp-8-Br-cGMPS, 51.2 ± 3.0% for L-arginine plus Rp-8-Br-cGMPS, and 45.5 ± 2.7% for PTIO. The differences were reported as statistically significant, with p < .05, and the study concluded that nitric oxide affects bovine sperm capacitation through both cGMP-dependent and cGMP-independent pathways.
Why Blocking May Backfire
In an in-vitro study of bovine sperm capacitation, inhibiting nitric oxide synthesis with AG decreased sperm quality during capacitation, except for mitochondrial activity. This finding runs against the idea that reducing nitric oxide synthesis will necessarily improve sperm quality. Interpretation is also limited by broader problems with fertility testing: basic semen analysis has variability and limited predictive value, although it remains the cornerstone of male-infertility evaluation. Morphological sperm evaluation alone has likewise been described as not predictive of reproductive competence.
What Does This Mean for Fertility Treatments?
This study sheds light on the complex role of NO in sperm capacitation. While blocking iNOS appears to have detrimental effects on sperm motility and integrity, the restoration of membrane integrity with NO addition suggests a more nuanced picture. Further research is needed to fully understand the different pathways through which NO affects sperm quality. Understanding how NO and related pathways influence sperm function could lead to new strategies for improving sperm quality and treating male infertility.
Beyond Conventional Semen Measures
Current male-infertility research is expanding beyond traditional semen parameters such as sperm concentration and motility to emphasize overall semen and sperm quality. The cited research agenda also highlights semen quality and oxidative stress as important areas of contemporary investigation. Future clinical work is expected to address continuing questions about the pathophysiology, diagnosis, and therapy of male infertility, with reproductive urologists playing an expanding role.
The Burden of Infertility Care
A systematic review examined the psychological, social, and sexual burden of male-infertility treatment on men. Its evidence base included 12 studies that varied in design, setting, and methods. The review also considered patient needs during clinical care, showing that male infertility involves challenges extending beyond laboratory measurements.
Personalized Fertility Assessment
One cited study states that infertility affects 1 in 6 couples and that male-fertility assessment often relies on semen analysis alone, despite its limited predictive value for treatment success. The study evaluated an epigenetic tool intended to provide a more comprehensive assessment of sperm quality and support personalized treatment strategies, using de-identified pregnancy outcomes from 537 participants. Another case-control source reports that infertility affects approximately 15% of couples and that male factors are major contributing causes in 40% to 60% of cases, emphasizing the need to evaluate both partners.